Equities
Consumer Staples Food Producers
  • Price (EUR)108.15
  • Today's Change-1.50 / -1.37%
  • Shares traded352.00k
  • 1 Year change-33.57%
  • Beta0.9832
Data delayed at least 15 minutes, as of Mar 30 2023 15:45 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company's segments include Nutrition, Materials, Innovation Center and Corporate Activities. Its Nutrition segment focuses on human nutrition & health, food & beverages, personal care and aroma ingredients and animal nutrition & health. Its Materials segment engages in specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. Its Innovation Center segment focuses on innovation and the growth of DSM’s existing core business through adjacent technologies via its Corporate Research Program, as well as through the Company’s venturing and licensing activities. Its Corporate Activities segment comprises operating and service activities.

  • Revenue in EUR (TTM)8.39bn
  • Net income in EUR454.00m
  • Incorporated1966
  • Employees20.68k
  • Location
    Koninklijke DSM NVHet Overloon 1HEERLEN 6411 TENetherlandsNLD
  • Phone+31 455788111
  • Fax+31 455742595
  • Websitehttps://www.dsm.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DSM:AEX since
announced
Transaction
value
Prodap LtdaDeal completed07 Jun 202207 Jun 2022Deal completed-29.77%--
Firmenich International SAAnnounced31 May 202231 May 2022Announced-25.75%20.72bn
Data delayed at least 15 minutes, as of Mar 30 2023 15:45 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AAK AB (publ)4.47bn157.06m4.22bn3.95k26.853.1718.450.94386.836.83194.6557.931.654.028.57--5.826.6110.1810.6519.3623.263.534.510.856115.360.324538.9242.2313.7923.178.198.4611.09
Emmi AG4.25bn183.24m4.87bn9.37k26.554.1415.291.1534.1234.12790.68218.581.665.838.39451,538.107.468.1811.1711.3335.0636.084.515.511.0310.800.350933.878.134.69-15.782.4715.597.71
Lotus Bakeries NV877.45m103.24m5.16bn2.40k49.718.9640.135.88127.13127.131,080.24705.530.84088.268.18--9.909.9912.5412.5339.6440.2411.7712.140.797388.900.317624.5816.9510.8613.7410.19--18.20
SalMar ASA1.87bn284.11m5.53bn1.83k15.713.2213.412.9527.3528.19176.27133.370.46710.931318.01--7.9711.9211.6516.3154.6354.3917.0619.820.962317.550.490183.5640.6414.3622.487.10--1.03
Orkla ASA5.17bn444.78m6.51bn20.47k14.601.769.771.265.035.0358.4941.810.7722--8.202,852,377.006.977.039.088.77--50.299.029.080.6008--0.306858.8915.768.104.397.3810.302.90
Mowi ASA4.93bn781.03m8.42bn13.73k10.722.416.851.7117.1417.14108.7276.400.71654.756.604,054,766.0011.398.3914.099.9052.4950.5815.9011.681.94--0.3943737.8017.586.2560.4611.095.63-10.05
Barry Callebaut AG8.12bn362.07m10.71bn13.42k29.593.6717.841.3265.6665.661,473.04529.701.083.089.66603,059.704.815.357.428.1615.0415.864.464.890.74964.550.417239.3112.273.52-6.055.164.596.96
JDE Peets NV8.15bn771.00m13.96bn19.99k17.971.2211.851.711.551.5516.4022.780.36844.6210.58407,835.503.442.894.353.8336.8741.459.348.860.3696--0.3085--16.434.531.1819.380.9969--
Kerry Group PLC8.77bn606.40m16.21bn23.00k26.852.6117.801.853.413.4149.3635.150.7409--6.73381,387.005.126.256.467.79--45.816.918.210.974613.470.339825.3919.346.48-20.522.51-6.0110.82
Koninklijke DSM N.V.8.39bn454.00m19.17bn20.68k41.831.7717.882.282.629.7948.4562.070.50212.465.39405,666.802.814.203.335.0532.0634.725.607.422.2420.280.220352.4115.42-0.5671-44.63-23.533.246.46
Chocoladefabriken Lindt & Spruengli AG4.99bn571.86m25.90bn14.47k44.795.7030.615.192,393.152,393.1520,825.8818,817.240.58822.055.14343,578.006.745.988.237.2366.2466.2211.4610.621.2832.230.246156.918.393.9816.154.804.426.93
Danone SA27.66bn945.00m38.55bn96.17k38.582.0413.221.391.481.4843.2628.020.60996.499.02287,638.002.323.573.134.7246.0547.763.816.320.78622.070.440572.9113.922.20-50.21-17.33-2.061.03
Data as of Mar 30 2023. Currency figures normalised to Koninklijke DSM NV's reporting currency: Euro EUR

Institutional shareholders

23.60%Per cent of shares held by top holders
HolderShares% Held
Norges Bank Investment Managementas of 02 Mar 20228.35m4.78%
Capital Research & Management Co. (World Investors)as of 31 Dec 20228.13m4.65%
Artisan Partners LPas of 08 Sep 20216.55m3.75%
The Vanguard Group, Inc.as of 03 Mar 20234.63m2.65%
BlackRock Fund Advisorsas of 01 Mar 20233.02m1.73%
Impax Asset Management Ltd.as of 28 Feb 20232.79m1.60%
BlackRock Investment Management (UK) Ltd.as of 21 Mar 20232.18m1.25%
BNP Paribas Asset Management France SASas of 28 Feb 20231.93m1.11%
Nordea Investment Management AB (Denmark)as of 31 Jan 20231.85m1.06%
BlackRock Advisors (UK) Ltd.as of 02 Mar 20231.80m1.03%
More ▼
Data from 31 Dec 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.